OR WAIT null SECS
August 26, 2025
Article
A brief history of intravitreal implants; where we started and how far we can still go to reduce treatment burden for patients and clinicians alike.
August 07, 2025
A month with few regulations instead saw significant research advancements presented at the American Society of Retina Specialists’ 2025 meeting.
August 05, 2025
Video
Recent phase 1/2 trial data indicate the safety and efficacy of the surgical, subretinal injection in monitoring cellular homeostasis.
August 02, 2025
Based on an open-label extension of the OAKS and DERBY trials, pegcetacoplan has highlighted the superior effectiveness of early versus delayed GA treatment.
August 01, 2025
Hahn discusses his recent study evaluating AREDS’s potential for nonsubfoveal GA regression in response to a recent post hoc analysis.
July 02, 2025
Our recap of the first half of 2025 highlights 5 regulatory updates, 5 trial announcements, and 3 top perspectives in eyecare.
July 01, 2025
Our Q2 2025 recap for ophthalmology highlights 5 regulatory updates, 5 important trial announcements, and top perspectives in eyecare.
June 30, 2025
June was characterized by HCPLive’s coverage of the AOA 2025 Conference in Minneapolis and a host of cross-specialty disease indicators and drug uses.
June 02, 2025
This May was characterized by HCPLive’s coverage of the ARVO and Envision conferences, as well as a slew of FDA approvals towards the end of the month.
May 25, 2025
Type 2 macular neovascularization, reductions in outer nuclear layer and central foveal thickness, and intraretinal fluid may indicate higher odds of retinal atrophy.
